Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negat... von Zheng, Jiani, Wu, Jingxun, Wang, Chunyue, Zhuang, Shiwen, Chen, Jianbo, Ye, Feng

Volltext

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer von Chen, Haojun, Pang, Yizhen, Wu, Jingxun, Zhao, Liang, Hao, Bing, Wu, Jing, Wei, Jihong, Wu, Siming, Zhao, Long, Luo, Zuoming, Lin, Xuehua, Xie, Chengrong, Sun, Long, Lin, Qin, Wu, Hua

Volltext

Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings von Chen, Haojun, Zhao, Liang, Ruan, Dan, Pang, Yizhen, Hao, Bing, Dai, Yaqing, Wu, Xiurong, Guo, Wei, Fan, Chunlei, Wu, Jingxun, Huang, Weipeng, Lin, Qin, Sun, Long, Wu, Hua

Volltext

Transcription factor KLF15 inhibits the proliferation and migration of gastric cancer cells via regulating the TFAP2A-AS1/NISCH axis von Zhao, Xin, Chen, Linlin, Wu, Jingxun, You, Jun, Hong, Qingqi, Ye, Feng

Volltext

National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China von Xue, Cong, Hu, Zhihuang, Jiang, Wei, Zhao, Yuanyuan, Xu, Fei, Huang, Yan, Zhao, Hongyun, Wu, Jingxun, Zhang, Yang, Zhao, Liping, Zhang, Jing, Chen, Likun, Zhang, Li

Volltext

Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases von Li, Yibin, Guo, Weixi, Jiang, Bin, Han, Chengkun, Ye, Feng, Wu, Jingxun

Volltext

ALYREF recruits ELAVL1 to promote colorectal tumorigenesis via facilitating RNA m5C recognition and nuclear export von Zhong, Longhua, Wu, Jingxun, Zhou, Bingqian, Kang, Jiapeng, Wang, Xicheng, Ye, Feng, Lin, Xiaoting

Volltext

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer von Zhao, Jun, Yu, Xinmin, Huang, Dingzhi, Ma, Zhiyong, Gao, Bo, Cui, Jiuwei, Chu, Qian, Zhou, Qing, Sun, Meili, Day, Daphne, Wu, Jingxun, Pan, Hongming, Wang, Lifeng, Voskoboynik, Mark, Wang, Zhehai, Liu, Yunpeng, Li, Hui, Zhang, Juan, Peng, Yanyan, Wu, Yi-Long

Volltext

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherap... von Zhang, Yang, Zhao, Liping, Huang, Peiyu, Wu, Jingxun, Wang, Fenghua, Huang, Yan, Zhang, Li

Volltext

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, plac... von Wang, Jie, Zhou, Caicun, Yao, Wenxiu, Wang, Qiming, Min, Xuhong, Chen, Gongyan, Xu, Xingxiang, Li, Xingya, Xu, Fei, Fang, Yong, Yang, Runxiang, Yu, Guohua, Gong, Youling, Zhao, Jun, Fan, Yun, Liu, Quan, Cao, Lejie, Yao, Yu, Liu, Yunpeng, Li, Xiaoling, Wu, Jingxun, He, Zhiyong, Lu, Kaihua, Jiang, Liyan, Hu, Chengping, Zhao, Wenhua, Zhang, Ben, Shi, Wei, Zhang, Xiaojing, Cheng, Ying, Cheng, Ying, Wang, Jie, Zhou, Caicun, Yao, Wenxiu, Wang, Qiming, Min, Xuhong, Chen, Gongyan, Xu, Xingxiang, Li, Xingya, Xu, Fei, Fang, Yong, Yang, Runxiang, Yu, Guohua, Gong, Youling, Zhao, Jun, Fan, Yun, Liu, Quan, Cao, Lejie, Yao, Yu, Liu, Yunpeng, Li, Xiaoling, Wu, Jingxun, He, Zhiyong, Lu, Kaihua, Jiang, Liyan, Hu, Chengping, Zhao, Wenhua, Yu, Huiqing, Zhao, Jian, Wu, Gang, Huang, Dingzhi, Chen, Chengshui, Ding, Cuimin, Zhang, Baihong, Wang, Xiuwen, Luo, Hui, Li, Baolan, Zhang, Shucai, Lu, Hong, Shi, Meiqi, Chen, Xi, Guo, Yubiao, Liu, Hailong, Liu, Jiwei, Gao, Hongjun, Hu, Sheng, Hong, Qunying, Li, Qi, Zhang, Ben, Shi, Wei, Zhang, Xiaojing

Volltext

The safety and efficacy for the treatment of alectinib in a women with ALK-positive lung cancer delivered a healthy male neonate throughout Pregnancy: A case report von Shang, Meijiao, Luo, Xi, Wu, Jingxun, Wang, ZeZheng, Chen, Qionghua, Zhou, Ying

Volltext

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01) von Wang, Zhijie, Wu, Lin, Li, Baolan, Cheng, Ying, Li, Xiaoling, Wang, Xicheng, Han, Liang, Wu, Xiaohong, Fan, Yun, Yu, Yan, Lv, Dongqing, Shi, Jianhua, Huang, Jianjin, Zhou, Shaozhang, Han, Baohui, Sun, Guogui, Guo, Qisen, Ji, Youxin, Zhu, Xiaoli, Hu, Sheng, Zhang, Wei, Wang, Qiming, Jia, Yuming, Wang, Ziping, Song, Yong, Wu, Jingxun, Shi, Meiqi, Li, Xingya, Han, Zhigang, Liu, Yunpeng, Yu, Zhuang, Liu, An-Wen, Wang, Xiuwen, Zhou, Caicun, Zhong, Diansheng, Miao, Liyun, Zhang, Zhihong, Zhao, Hui, Yang, Jun, Wang, Dong, Wang, Yingyi, Li, Qiang, Zhang, Xiaodong, Ji, Mei, Yang, Zhenzhou, Cui, Jiuwei, Gao, Beili, Wang, Buhai, Liu, Hu, Nie, Lei, He, Mei, Jin, Shi, Gu, Wei, Shu, Yongqian, Zhou, Tong, Feng, Jian, Yang, Xinmei, Huang, Cheng, Zhu, Bo, Yao, Yu, Tang, Xiongwen, Yu, Jianjun, Maher, Ellen, Feng, Hui, Yao, Sheng, Keegan, Patricia, Wang, Jie

Volltext

A study to evaluate the safety, tolerability, and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastati... von Wu, Chunjiao, Liu, Baogang, Wu, Lin, Zhang, Tongmei, Wang, Ke, Miao, Liyun, Wu, Jingxun, Wang, Huijuan, Fang, Jian, Li, Xingya, Zhang, Wei, Hu, Yanping, Mei, Xiaodong, Song, Yong, Zhu, Jing, Xin, Ying, He, Yue, Chen, Yuling, Ye, Jiawei, Cheng, Ying

Volltext

Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer von Drilon, Alexander, Camidge, D. Ross, Lin, Jessica J., Kim, Sang-We, Solomon, Benjamin J., Dziadziuszko, Rafal, Besse, Benjamin, Goto, Koichi, de Langen, Adrianus Johannes, Wolf, Jürgen, Lee, Ki Hyeong, Popat, Sanjay, Springfeld, Christoph, Nagasaka, Misako, Felip, Enriqueta, Yang, Nong, Velcheti, Vamsidhar, Lu, Shun, Kao, Steven, Dooms, Christophe, Krebs, Matthew G., Yao, Wenxiu, Beg, Muhammad Shaalan, Hu, Xiufeng, Moro-Sibilot, Denis, Cheema, Parneet, Stopatschinskaja, Shanna, Mehta, Minal, Trone, Denise, Graber, Armin, Sims, Gregory, Yuan, Yong, Cho, Byoung Chul

Volltext

Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib von Li, Yibin, Lin, Yantang, Wu, Jingxun, Ye, Feng

Volltext

The efficacy and safety of taletrectinib in patients with TKI-naïve or crizotinib-pretreated ROS1-positive non–small cell lung cancer (NSCLC) von Li, Wei, Yang, Nong, Ma, HuiWen, Fan, Huijie, Li, Kunyan, Wu, Huijuan, Yu, Qitao, Wang, Yongsheng, Meng, Xue, Wang, Xicheng, Qin, Xintian, Wang, Ziping, Liu, Yunpeng, Tao, Min, Zhuang, Wu, Fang, Yong, Sun, Ping, Lu, Kaihua, Wu, Jingxun, Zhou, Caicun

Volltext

Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study von Zhao, Yu, Xiong, Shan, Ren, Qin, Wang, Jun, Li, Min, Yang, Lin, Wu, Di, Tang, Kejing, Pan, Xiaojie, Chen, Fengxia, Wang, Wenxiang, Jin, Shi, Liu, Xianling, Lin, Gen, Yao, Wenxiu, Cai, Linbo, Yang, Yi, Liu, Jixian, Wu, Jingxun, Fu, Wenfan, Sun, Kai, Li, Feng, Cheng, Bo, Zhan, Shuting, Wang, Haixuan, Yu, Ziwen, Liu, Xiwen, Zhong, Ran, Wang, Huiting, He, Ping, Zheng, Yongmei, Liang, Peng, Chen, Longfei, Hou, Ting, Huang, Junzhou, He, Bing, Song, Jiangning, Wu, Lin, Hu, Chengping, He, Jianxing, Yao, Jianhua, Liang, Wenhua

Volltext

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC von Wu, Xuan, Liang, Wenhua, Hou, Xue, Lin, Zhong, Zhao, Hongyun, Huang, Yan, Fang, Wenfeng, Zhao, Yuanyuan, Wu, Jingxun, Yang, Yunpeng, Xue, Chong, Hu, Zhihuang, Zhang, Jing, Zhang, Jianwei, Ma, Yuxiang, Zhou, Ting, Qin, Tao, Zhang, Li

Volltext

RATIONALE-307: Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous NSCLC in patients aged ≥ 65 von Wang, Jie, Lu, Shun, Yu, Xinmin, Hu, Yanping, Sun, Yuping, Wang, Zhijie, Zhao, Jun, Yu, Yan, Hu, Chunhong, Yang, Kunyu, Feng, Guosheng, Ying, Kejing, Zhuang, Wu, Zhou, Jianying, Wu, Jingxun, Leaw, Shiang Jiin, Zhang, Jing, Lin, Xiao, Yang, Nong

Volltext

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer von Xu, Jiachen, Wan, Rui, Cai, Yiran, Cai, Shangli, Wu, Lin, Li, Baolan, Duan, Jianchun, Cheng, Ying, Li, Xiaoling, Wang, Xicheng, Han, Liang, Wu, Xiaohong, Fan, Yun, Yu, Yan, Lv, Dongqing, Shi, Jianhua, Huang, Jianjin, Zhou, Shaozhang, Han, Baohui, Sun, Guogui, Guo, Qisen, Ji, Youxin, Zhu, Xiaoli, Hu, Sheng, Zhang, Wei, Wang, Qiming, Jia, Yuming, Wang, Ziping, Song, Yong, Wu, Jingxun, Shi, Meiqi, Li, Xingya, Han, Zhigang, Liu, Yunpeng, Yu, Zhuang, Liu, An-Wen, Wang, Xiuwen, Zhou, Caicun, Zhong, Diansheng, Miao, Liyun, Zhang, Zhihong, Zhao, Hui, Yang, Jun, Wang, Dong, Wang, Yingyi, Li, Qiang, Zhang, Xiaodong, Ji, Mei, Yang, Zhenzhou, Cui, Jiuwei, Gao, Beili, Wang, Buhai, Liu, Hu, Nie, Lei, He, Mei, Jin, Shi, Gu, Wei, Shu, Yongqian, Zhou, Tong, Feng, Jian, Yang, Xinmei, Huang, Cheng, Zhu, Bo, Yao, Yu, Yu, Jianjun, Yao, Sheng, Shen, Runxi, Wang, Zhijie, Wang, Jie

Volltext